nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimetrexate—DHFR—Methotrexate—stomach cancer	0.739	1	CbGbCtD
Trimetrexate—DHFR—Fluoropyrimidine Activity—XRCC3—stomach cancer	0.00538	0.0423	CbGpPWpGaD
Trimetrexate—Trimethoprim—TYMS—stomach cancer	0.00524	1	CrCbGaD
Trimetrexate—DHFR—Fluoropyrimidine Activity—UMPS—stomach cancer	0.00516	0.0405	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism of folate and pterines—MTHFR—stomach cancer	0.00503	0.0395	CbGpPWpGaD
Trimetrexate—Electrolyte imbalance—Irinotecan—stomach cancer	0.00495	0.0387	CcSEcCtD
Trimetrexate—DHFR—Fluoropyrimidine Activity—TYMP—stomach cancer	0.00451	0.0354	CbGpPWpGaD
Trimetrexate—DHFR—One Carbon Metabolism—DNMT3B—stomach cancer	0.00446	0.035	CbGpPWpGaD
Trimetrexate—DHFR—Trans-sulfuration and one carbon metabolism—DNMT3B—stomach cancer	0.00401	0.0315	CbGpPWpGaD
Trimetrexate—DHFR—Fluoropyrimidine Activity—DPYD—stomach cancer	0.00358	0.0281	CbGpPWpGaD
Trimetrexate—DHFR—G1/S-Specific Transcription—TYMS—stomach cancer	0.00346	0.0272	CbGpPWpGaD
Trimetrexate—Serum creatinine increased—Irinotecan—stomach cancer	0.00336	0.0263	CcSEcCtD
Trimetrexate—DHFR—One Carbon Metabolism—DNMT1—stomach cancer	0.00331	0.026	CbGpPWpGaD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—RBP1—stomach cancer	0.00327	0.0257	CbGpPWpGaD
Trimetrexate—DHFR—Fluoropyrimidine Activity—CYP2A6—stomach cancer	0.00313	0.0246	CbGpPWpGaD
Trimetrexate—DHFR—Trans-sulfuration and one carbon metabolism—DNMT1—stomach cancer	0.00298	0.0234	CbGpPWpGaD
Trimetrexate—DHFR—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—NOS3—stomach cancer	0.00279	0.0219	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism of nitric oxide—CAV1—stomach cancer	0.00255	0.0201	CbGpPWpGaD
Trimetrexate—Anaemia—Floxuridine—stomach cancer	0.00245	0.0191	CcSEcCtD
Trimetrexate—DHFR—One Carbon Metabolism—TYMS—stomach cancer	0.00232	0.0183	CbGpPWpGaD
Trimetrexate—Serum creatinine increased—Capecitabine—stomach cancer	0.00225	0.0176	CcSEcCtD
Trimetrexate—DHFR—E2F mediated regulation of DNA replication—PPP2R1A—stomach cancer	0.00223	0.0176	CbGpPWpGaD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—CDKN2D—stomach cancer	0.00221	0.0173	CbGpPWpGaD
Trimetrexate—Blood bilirubin increased—Irinotecan—stomach cancer	0.00219	0.0171	CcSEcCtD
Trimetrexate—Confusional state—Floxuridine—stomach cancer	0.00218	0.017	CcSEcCtD
Trimetrexate—Thrombocytopenia—Floxuridine—stomach cancer	0.00212	0.0166	CcSEcCtD
Trimetrexate—DHFR—Trans-sulfuration and one carbon metabolism—TYMS—stomach cancer	0.00209	0.0164	CbGpPWpGaD
Trimetrexate—DHFR—E2F transcription factor network—XRCC1—stomach cancer	0.00207	0.0163	CbGpPWpGaD
Trimetrexate—Phosphatase alkaline increased—Irinotecan—stomach cancer	0.00207	0.0162	CcSEcCtD
Trimetrexate—DHFR—Fluoropyrimidine Activity—TYMS—stomach cancer	0.00204	0.016	CbGpPWpGaD
Trimetrexate—DHFR—E2F mediated regulation of DNA replication—TYMS—stomach cancer	0.00204	0.016	CbGpPWpGaD
Trimetrexate—DHFR—One Carbon Metabolism—MTHFR—stomach cancer	0.00203	0.0159	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism of nitric oxide—NOS3—stomach cancer	0.00193	0.0152	CbGpPWpGaD
Trimetrexate—Anaemia—Mitomycin—stomach cancer	0.00192	0.015	CcSEcCtD
Trimetrexate—DHFR—Fluoropyrimidine Activity—ERCC2—stomach cancer	0.00189	0.0149	CbGpPWpGaD
Trimetrexate—Hepatotoxicity—Docetaxel—stomach cancer	0.00185	0.0145	CcSEcCtD
Trimetrexate—DHFR—Trans-sulfuration and one carbon metabolism—MTHFR—stomach cancer	0.00182	0.0143	CbGpPWpGaD
Trimetrexate—Hepatotoxicity—Capecitabine—stomach cancer	0.00179	0.014	CcSEcCtD
Trimetrexate—Feeling abnormal—Floxuridine—stomach cancer	0.00178	0.0139	CcSEcCtD
Trimetrexate—DHFR—Fluoropyrimidine Activity—MTHFR—stomach cancer	0.00178	0.014	CbGpPWpGaD
Trimetrexate—Blood alkaline phosphatase increased—Irinotecan—stomach cancer	0.00173	0.0135	CcSEcCtD
Trimetrexate—Confusional state—Mitomycin—stomach cancer	0.00171	0.0134	CcSEcCtD
Trimetrexate—Body temperature increased—Floxuridine—stomach cancer	0.00171	0.0134	CcSEcCtD
Trimetrexate—Thrombocytopenia—Mitomycin—stomach cancer	0.00166	0.013	CcSEcCtD
Trimetrexate—Serum creatinine increased—Epirubicin—stomach cancer	0.00157	0.0122	CcSEcCtD
Trimetrexate—Asthenia—Floxuridine—stomach cancer	0.00155	0.0121	CcSEcCtD
Trimetrexate—Hypocalcaemia—Capecitabine—stomach cancer	0.00151	0.0118	CcSEcCtD
Trimetrexate—Blood bilirubin increased—Docetaxel—stomach cancer	0.00151	0.0118	CcSEcCtD
Trimetrexate—Hyponatraemia—Irinotecan—stomach cancer	0.00151	0.0118	CcSEcCtD
Trimetrexate—Fatigue—Mitomycin—stomach cancer	0.00146	0.0114	CcSEcCtD
Trimetrexate—Blood bilirubin increased—Capecitabine—stomach cancer	0.00146	0.0114	CcSEcCtD
Trimetrexate—Serum creatinine increased—Doxorubicin—stomach cancer	0.00145	0.0113	CcSEcCtD
Trimetrexate—Phosphatase alkaline increased—Docetaxel—stomach cancer	0.00143	0.0112	CcSEcCtD
Trimetrexate—Blood creatinine increased—Irinotecan—stomach cancer	0.00141	0.011	CcSEcCtD
Trimetrexate—Feeling abnormal—Mitomycin—stomach cancer	0.0014	0.0109	CcSEcCtD
Trimetrexate—Phosphatase alkaline increased—Capecitabine—stomach cancer	0.00138	0.0108	CcSEcCtD
Trimetrexate—Vomiting—Floxuridine—stomach cancer	0.00138	0.0108	CcSEcCtD
Trimetrexate—Rash—Floxuridine—stomach cancer	0.00137	0.0107	CcSEcCtD
Trimetrexate—Dermatitis—Floxuridine—stomach cancer	0.00136	0.0107	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Irinotecan—stomach cancer	0.00135	0.0106	CcSEcCtD
Trimetrexate—Body temperature increased—Mitomycin—stomach cancer	0.00134	0.0105	CcSEcCtD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—DNMT1—stomach cancer	0.00134	0.0105	CbGpPWpGaD
Trimetrexate—Hepatotoxicity—Methotrexate—stomach cancer	0.00133	0.0104	CcSEcCtD
Trimetrexate—Nausea—Floxuridine—stomach cancer	0.00129	0.01	CcSEcCtD
Trimetrexate—Asthenia—Mitomycin—stomach cancer	0.00122	0.00952	CcSEcCtD
Trimetrexate—Neutropenia—Irinotecan—stomach cancer	0.00121	0.00948	CcSEcCtD
Trimetrexate—Blood alkaline phosphatase increased—Docetaxel—stomach cancer	0.00119	0.00932	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—SOD2—stomach cancer	0.00116	0.00912	CbGpPWpGaD
Trimetrexate—Blood alkaline phosphatase increased—Capecitabine—stomach cancer	0.00116	0.00902	CcSEcCtD
Trimetrexate—Vomiting—Mitomycin—stomach cancer	0.00108	0.00844	CcSEcCtD
Trimetrexate—DHFR—E2F transcription factor network—TYMS—stomach cancer	0.00108	0.00848	CbGpPWpGaD
Trimetrexate—Rash—Mitomycin—stomach cancer	0.00107	0.00837	CcSEcCtD
Trimetrexate—Dermatitis—Mitomycin—stomach cancer	0.00107	0.00836	CcSEcCtD
Trimetrexate—Hypocalcaemia—Epirubicin—stomach cancer	0.00105	0.00823	CcSEcCtD
Trimetrexate—Hyponatraemia—Docetaxel—stomach cancer	0.00104	0.00814	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—MTHFR—stomach cancer	0.00102	0.00803	CbGpPWpGaD
Trimetrexate—Blood bilirubin increased—Epirubicin—stomach cancer	0.00102	0.00796	CcSEcCtD
Trimetrexate—Nausea—Mitomycin—stomach cancer	0.00101	0.00788	CcSEcCtD
Trimetrexate—Hyponatraemia—Capecitabine—stomach cancer	0.00101	0.00788	CcSEcCtD
Trimetrexate—Hypocalcaemia—Doxorubicin—stomach cancer	0.000975	0.00761	CcSEcCtD
Trimetrexate—Phosphatase alkaline increased—Epirubicin—stomach cancer	0.000964	0.00753	CcSEcCtD
Trimetrexate—Blood bilirubin increased—Doxorubicin—stomach cancer	0.000943	0.00737	CcSEcCtD
Trimetrexate—Blood creatinine increased—Capecitabine—stomach cancer	0.000941	0.00735	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—APOA1—stomach cancer	0.000941	0.00739	CbGpPWpGaD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—TYMS—stomach cancer	0.000938	0.00737	CbGpPWpGaD
Trimetrexate—Aspartate aminotransferase increased—Docetaxel—stomach cancer	0.000935	0.0073	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Docetaxel—stomach cancer	0.000915	0.00715	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Capecitabine—stomach cancer	0.000905	0.00707	CcSEcCtD
Trimetrexate—Phosphatase alkaline increased—Doxorubicin—stomach cancer	0.000892	0.00697	CcSEcCtD
Trimetrexate—DHFR—E2F transcription factor network—PLAU—stomach cancer	0.000891	0.007	CbGpPWpGaD
Trimetrexate—Alanine aminotransferase increased—Capecitabine—stomach cancer	0.000886	0.00692	CcSEcCtD
Trimetrexate—DHFR—G1/S Transition—PPP2R1A—stomach cancer	0.000859	0.00675	CbGpPWpGaD
Trimetrexate—Neutropenia—Docetaxel—stomach cancer	0.000839	0.00655	CcSEcCtD
Trimetrexate—Anaemia—Irinotecan—stomach cancer	0.000836	0.00653	CcSEcCtD
Trimetrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—stomach cancer	0.00082	0.00644	CbGpPWpGaD
Trimetrexate—Neutropenia—Capecitabine—stomach cancer	0.000812	0.00634	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle, Mitotic—CDKN2D—stomach cancer	0.000809	0.00635	CbGpPWpGaD
Trimetrexate—Blood alkaline phosphatase increased—Epirubicin—stomach cancer	0.000805	0.00628	CcSEcCtD
Trimetrexate—Anaemia—Fluorouracil—stomach cancer	0.0008	0.00625	CcSEcCtD
Trimetrexate—DHFR—G1/S Transition—TYMS—stomach cancer	0.000783	0.00615	CbGpPWpGaD
Trimetrexate—Convulsion—Fluorouracil—stomach cancer	0.00075	0.00586	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—SERPINE1—stomach cancer	0.000747	0.00587	CbGpPWpGaD
Trimetrexate—DHFR—Folate Metabolism—ALB—stomach cancer	0.000745	0.00586	CbGpPWpGaD
Trimetrexate—Blood alkaline phosphatase increased—Doxorubicin—stomach cancer	0.000745	0.00582	CcSEcCtD
Trimetrexate—Confusional state—Irinotecan—stomach cancer	0.000744	0.00581	CcSEcCtD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—CDK4—stomach cancer	0.000732	0.00575	CbGpPWpGaD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—PPP2R1A—stomach cancer	0.000724	0.00569	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—CDKN2D—stomach cancer	0.000723	0.00568	CbGpPWpGaD
Trimetrexate—Thrombocytopenia—Irinotecan—stomach cancer	0.000723	0.00564	CcSEcCtD
Trimetrexate—Confusional state—Fluorouracil—stomach cancer	0.000713	0.00556	CcSEcCtD
Trimetrexate—Hyponatraemia—Epirubicin—stomach cancer	0.000703	0.00549	CcSEcCtD
Trimetrexate—Thrombocytopenia—Fluorouracil—stomach cancer	0.000692	0.0054	CcSEcCtD
Trimetrexate—DHFR—E2F transcription factor network—SERPINE1—stomach cancer	0.000689	0.00541	CbGpPWpGaD
Trimetrexate—DHFR—Fluoropyrimidine Activity—TP53—stomach cancer	0.000676	0.00531	CbGpPWpGaD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—TYMS—stomach cancer	0.00066	0.00519	CbGpPWpGaD
Trimetrexate—Blood creatinine increased—Epirubicin—stomach cancer	0.000656	0.00512	CcSEcCtD
Trimetrexate—Hyponatraemia—Doxorubicin—stomach cancer	0.00065	0.00508	CcSEcCtD
Trimetrexate—DHFR—E2F transcription factor network—CDKN2A—stomach cancer	0.000643	0.00505	CbGpPWpGaD
Trimetrexate—Fatigue—Irinotecan—stomach cancer	0.000636	0.00497	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Epirubicin—stomach cancer	0.00063	0.00492	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Epirubicin—stomach cancer	0.000617	0.00482	CcSEcCtD
Trimetrexate—Feeling abnormal—Irinotecan—stomach cancer	0.000608	0.00475	CcSEcCtD
Trimetrexate—Blood creatinine increased—Doxorubicin—stomach cancer	0.000607	0.00474	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—IL1B—stomach cancer	0.000607	0.00477	CbGpPWpGaD
Trimetrexate—Neutropenia—Methotrexate—stomach cancer	0.000605	0.00472	CcSEcCtD
Trimetrexate—Body temperature increased—Irinotecan—stomach cancer	0.000583	0.00456	CcSEcCtD
Trimetrexate—Aspartate aminotransferase increased—Doxorubicin—stomach cancer	0.000583	0.00455	CcSEcCtD
Trimetrexate—Feeling abnormal—Fluorouracil—stomach cancer	0.000582	0.00455	CcSEcCtD
Trimetrexate—Anaemia—Docetaxel—stomach cancer	0.000578	0.00451	CcSEcCtD
Trimetrexate—Alanine aminotransferase increased—Doxorubicin—stomach cancer	0.000571	0.00446	CcSEcCtD
Trimetrexate—DHFR—E2F transcription factor network—CDKN1B—stomach cancer	0.00057	0.00448	CbGpPWpGaD
Trimetrexate—Neutropenia—Epirubicin—stomach cancer	0.000566	0.00442	CcSEcCtD
Trimetrexate—Anaemia—Capecitabine—stomach cancer	0.000559	0.00437	CcSEcCtD
Trimetrexate—Body temperature increased—Fluorouracil—stomach cancer	0.000559	0.00436	CcSEcCtD
Trimetrexate—Convulsion—Docetaxel—stomach cancer	0.000542	0.00423	CcSEcCtD
Trimetrexate—Asthenia—Irinotecan—stomach cancer	0.000529	0.00413	CcSEcCtD
Trimetrexate—DHFR—E2F transcription factor network—CDKN1A—stomach cancer	0.000526	0.00413	CbGpPWpGaD
Trimetrexate—Neutropenia—Doxorubicin—stomach cancer	0.000523	0.00409	CcSEcCtD
Trimetrexate—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—stomach cancer	0.000523	0.00411	CbGpPWpGaD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—CDK4—stomach cancer	0.000515	0.00404	CbGpPWpGaD
Trimetrexate—Confusional state—Docetaxel—stomach cancer	0.000514	0.00402	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle, Mitotic—AURKB—stomach cancer	0.000508	0.00399	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ACAD8—stomach cancer	0.000503	0.00395	CbGpPWpGaD
Trimetrexate—Pruritus—Fluorouracil—stomach cancer	0.0005	0.0039	CcSEcCtD
Trimetrexate—Thrombocytopenia—Docetaxel—stomach cancer	0.000499	0.0039	CcSEcCtD
Trimetrexate—Confusional state—Capecitabine—stomach cancer	0.000498	0.00389	CcSEcCtD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—CDKN1B—stomach cancer	0.000495	0.00389	CbGpPWpGaD
Trimetrexate—Thrombocytopenia—Capecitabine—stomach cancer	0.000484	0.00378	CcSEcCtD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—CCND1—stomach cancer	0.000472	0.00371	CbGpPWpGaD
Trimetrexate—Vomiting—Irinotecan—stomach cancer	0.000469	0.00366	CcSEcCtD
Trimetrexate—Rash—Irinotecan—stomach cancer	0.000465	0.00363	CcSEcCtD
Trimetrexate—Dermatitis—Irinotecan—stomach cancer	0.000465	0.00363	CcSEcCtD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—CDKN1A—stomach cancer	0.000457	0.00359	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—AURKB—stomach cancer	0.000454	0.00357	CbGpPWpGaD
Trimetrexate—Vomiting—Fluorouracil—stomach cancer	0.000449	0.00351	CcSEcCtD
Trimetrexate—DHFR—Metabolism—GMPR2—stomach cancer	0.000448	0.00352	CbGpPWpGaD
Trimetrexate—Rash—Fluorouracil—stomach cancer	0.000446	0.00348	CcSEcCtD
Trimetrexate—Dermatitis—Fluorouracil—stomach cancer	0.000445	0.00348	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—TNF—stomach cancer	0.00044	0.00346	CbGpPWpGaD
Trimetrexate—Fatigue—Docetaxel—stomach cancer	0.00044	0.00343	CcSEcCtD
Trimetrexate—Nausea—Irinotecan—stomach cancer	0.000438	0.00342	CcSEcCtD
Trimetrexate—DHFR—E2F transcription factor network—MYC—stomach cancer	0.000436	0.00343	CbGpPWpGaD
Trimetrexate—Fatigue—Capecitabine—stomach cancer	0.000426	0.00333	CcSEcCtD
Trimetrexate—Feeling abnormal—Docetaxel—stomach cancer	0.00042	0.00328	CcSEcCtD
Trimetrexate—Nausea—Fluorouracil—stomach cancer	0.00042	0.00328	CcSEcCtD
Trimetrexate—Anaemia—Methotrexate—stomach cancer	0.000416	0.00325	CcSEcCtD
Trimetrexate—DHFR—G1/S Transition—CDKN1B—stomach cancer	0.000414	0.00325	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—SUCLG1—stomach cancer	0.00041	0.00322	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—IDH3B—stomach cancer	0.00041	0.00322	CbGpPWpGaD
Trimetrexate—Feeling abnormal—Capecitabine—stomach cancer	0.000407	0.00318	CcSEcCtD
Trimetrexate—DHFR—Disease—PGLS—stomach cancer	0.000406	0.00319	CbGpPWpGaD
Trimetrexate—Body temperature increased—Docetaxel—stomach cancer	0.000403	0.00315	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—NPM1—stomach cancer	0.0004	0.00314	CbGpPWpGaD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—CDKN2A—stomach cancer	0.000393	0.00309	CbGpPWpGaD
Trimetrexate—Body temperature increased—Capecitabine—stomach cancer	0.00039	0.00305	CcSEcCtD
Trimetrexate—Convulsion—Methotrexate—stomach cancer	0.00039	0.00305	CcSEcCtD
Trimetrexate—Anaemia—Epirubicin—stomach cancer	0.00039	0.00304	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—TP53—stomach cancer	0.000388	0.00305	CbGpPWpGaD
Trimetrexate—DHFR—Disease—RBP1—stomach cancer	0.000387	0.00304	CbGpPWpGaD
Trimetrexate—DHFR—G1/S Transition—CDKN1A—stomach cancer	0.000382	0.003	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—NDUFV1—stomach cancer	0.000381	0.00299	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—NDUFS1—stomach cancer	0.000381	0.00299	CbGpPWpGaD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—MYC—stomach cancer	0.000379	0.00298	CbGpPWpGaD
Trimetrexate—Confusional state—Methotrexate—stomach cancer	0.000371	0.00289	CcSEcCtD
Trimetrexate—Asthenia—Docetaxel—stomach cancer	0.000366	0.00286	CcSEcCtD
Trimetrexate—Convulsion—Epirubicin—stomach cancer	0.000365	0.00285	CcSEcCtD
Trimetrexate—Pruritus—Docetaxel—stomach cancer	0.000361	0.00282	CcSEcCtD
Trimetrexate—Anaemia—Doxorubicin—stomach cancer	0.000361	0.00282	CcSEcCtD
Trimetrexate—Thrombocytopenia—Methotrexate—stomach cancer	0.00036	0.00281	CcSEcCtD
Trimetrexate—DHFR—Folate Metabolism—IL6—stomach cancer	0.000355	0.00279	CbGpPWpGaD
Trimetrexate—Asthenia—Capecitabine—stomach cancer	0.000354	0.00277	CcSEcCtD
Trimetrexate—Pruritus—Capecitabine—stomach cancer	0.000349	0.00273	CcSEcCtD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—CDKN1B—stomach cancer	0.000348	0.00274	CbGpPWpGaD
Trimetrexate—Confusional state—Epirubicin—stomach cancer	0.000347	0.00271	CcSEcCtD
Trimetrexate—DHFR—Disease—FBP1—stomach cancer	0.000345	0.00271	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PGLS—stomach cancer	0.00034	0.00267	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—BLVRB—stomach cancer	0.00034	0.00267	CbGpPWpGaD
Trimetrexate—Convulsion—Doxorubicin—stomach cancer	0.000338	0.00264	CcSEcCtD
Trimetrexate—Thrombocytopenia—Epirubicin—stomach cancer	0.000337	0.00263	CcSEcCtD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—CCND1—stomach cancer	0.000332	0.00261	CbGpPWpGaD
Trimetrexate—Vomiting—Docetaxel—stomach cancer	0.000324	0.00253	CcSEcCtD
Trimetrexate—DHFR—Metabolism—PPAP2A—stomach cancer	0.000324	0.00255	CbGpPWpGaD
Trimetrexate—Rash—Docetaxel—stomach cancer	0.000322	0.00251	CcSEcCtD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—CDKN1A—stomach cancer	0.000322	0.00253	CbGpPWpGaD
Trimetrexate—Dermatitis—Docetaxel—stomach cancer	0.000321	0.00251	CcSEcCtD
Trimetrexate—Confusional state—Doxorubicin—stomach cancer	0.000321	0.00251	CcSEcCtD
Trimetrexate—Fatigue—Methotrexate—stomach cancer	0.000317	0.00248	CcSEcCtD
Trimetrexate—DHFR—G1/S Transition—MYC—stomach cancer	0.000316	0.00249	CbGpPWpGaD
Trimetrexate—Vomiting—Capecitabine—stomach cancer	0.000314	0.00245	CcSEcCtD
Trimetrexate—Thrombocytopenia—Doxorubicin—stomach cancer	0.000312	0.00243	CcSEcCtD
Trimetrexate—Rash—Capecitabine—stomach cancer	0.000311	0.00243	CcSEcCtD
Trimetrexate—DHFR—Retinoblastoma (RB) in Cancer—TP53—stomach cancer	0.000311	0.00244	CbGpPWpGaD
Trimetrexate—Dermatitis—Capecitabine—stomach cancer	0.000311	0.00243	CcSEcCtD
Trimetrexate—DHFR—Disease—PGAM1—stomach cancer	0.000307	0.00242	CbGpPWpGaD
Trimetrexate—Nausea—Docetaxel—stomach cancer	0.000303	0.00237	CcSEcCtD
Trimetrexate—Feeling abnormal—Methotrexate—stomach cancer	0.000303	0.00237	CcSEcCtD
Trimetrexate—Fatigue—Epirubicin—stomach cancer	0.000297	0.00232	CcSEcCtD
Trimetrexate—Nausea—Capecitabine—stomach cancer	0.000293	0.00229	CcSEcCtD
Trimetrexate—DHFR—Disease—WIF1—stomach cancer	0.000293	0.0023	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—APEX1—stomach cancer	0.000292	0.00229	CbGpPWpGaD
Trimetrexate—Body temperature increased—Methotrexate—stomach cancer	0.000291	0.00227	CcSEcCtD
Trimetrexate—DHFR—Metabolism—NDUFA2—stomach cancer	0.000289	0.00227	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CKB—stomach cancer	0.000289	0.00227	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—FBP1—stomach cancer	0.000289	0.00227	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CA1—stomach cancer	0.000289	0.00227	CbGpPWpGaD
Trimetrexate—Feeling abnormal—Epirubicin—stomach cancer	0.000284	0.00221	CcSEcCtD
Trimetrexate—DHFR—Disease—RPL18—stomach cancer	0.000276	0.00217	CbGpPWpGaD
Trimetrexate—DHFR—Disease—RPL13—stomach cancer	0.000276	0.00217	CbGpPWpGaD
Trimetrexate—Fatigue—Doxorubicin—stomach cancer	0.000274	0.00214	CcSEcCtD
Trimetrexate—Body temperature increased—Epirubicin—stomach cancer	0.000272	0.00212	CcSEcCtD
Trimetrexate—DHFR—Metabolism—PLIN2—stomach cancer	0.000272	0.00213	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—CHEK2—stomach cancer	0.000269	0.00211	CbGpPWpGaD
Trimetrexate—DHFR—Mitotic G1-G1/S phases—MYC—stomach cancer	0.000267	0.00209	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—PPP2R1A—stomach cancer	0.000266	0.00209	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CA2—stomach cancer	0.000264	0.00208	CbGpPWpGaD
Trimetrexate—Asthenia—Methotrexate—stomach cancer	0.000264	0.00206	CcSEcCtD
Trimetrexate—Feeling abnormal—Doxorubicin—stomach cancer	0.000262	0.00205	CcSEcCtD
Trimetrexate—DHFR—Disease—RNF43—stomach cancer	0.000261	0.00205	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—APEX1—stomach cancer	0.000261	0.00205	CbGpPWpGaD
Trimetrexate—Pruritus—Methotrexate—stomach cancer	0.00026	0.00203	CcSEcCtD
Trimetrexate—DHFR—Metabolism—NT5E—stomach cancer	0.000257	0.00202	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PGAM1—stomach cancer	0.000257	0.00202	CbGpPWpGaD
Trimetrexate—DHFR—Disease—RPS21—stomach cancer	0.000257	0.00202	CbGpPWpGaD
Trimetrexate—DHFR—Disease—RPS15—stomach cancer	0.000257	0.00202	CbGpPWpGaD
Trimetrexate—Body temperature increased—Doxorubicin—stomach cancer	0.000252	0.00197	CcSEcCtD
Trimetrexate—Asthenia—Epirubicin—stomach cancer	0.000247	0.00193	CcSEcCtD
Trimetrexate—DHFR—Metabolism—ALDH7A1—stomach cancer	0.000246	0.00193	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PLCE1—stomach cancer	0.000246	0.00193	CbGpPWpGaD
Trimetrexate—Pruritus—Epirubicin—stomach cancer	0.000243	0.0019	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle, Mitotic—TYMS—stomach cancer	0.000242	0.0019	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—PPP2R1A—stomach cancer	0.000237	0.00186	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—UMPS—stomach cancer	0.000236	0.00185	CbGpPWpGaD
Trimetrexate—Vomiting—Methotrexate—stomach cancer	0.000234	0.00183	CcSEcCtD
Trimetrexate—Rash—Methotrexate—stomach cancer	0.000232	0.00181	CcSEcCtD
Trimetrexate—Dermatitis—Methotrexate—stomach cancer	0.000232	0.00181	CcSEcCtD
Trimetrexate—Asthenia—Doxorubicin—stomach cancer	0.000228	0.00178	CcSEcCtD
Trimetrexate—Pruritus—Doxorubicin—stomach cancer	0.000225	0.00176	CcSEcCtD
Trimetrexate—DHFR—Metabolism—PDHA1—stomach cancer	0.000219	0.00172	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ECHS1—stomach cancer	0.000219	0.00172	CbGpPWpGaD
Trimetrexate—Vomiting—Epirubicin—stomach cancer	0.000219	0.00171	CcSEcCtD
Trimetrexate—Nausea—Methotrexate—stomach cancer	0.000218	0.00171	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle, Mitotic—BIRC5—stomach cancer	0.000218	0.00171	CbGpPWpGaD
Trimetrexate—Rash—Epirubicin—stomach cancer	0.000217	0.00169	CcSEcCtD
Trimetrexate—Dermatitis—Epirubicin—stomach cancer	0.000217	0.00169	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle—TYMS—stomach cancer	0.000217	0.0017	CbGpPWpGaD
Trimetrexate—DHFR—Disease—ALDOB—stomach cancer	0.000213	0.00167	CbGpPWpGaD
Trimetrexate—DHFR—Disease—RPL15—stomach cancer	0.000209	0.00164	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—FADS1—stomach cancer	0.000206	0.00162	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—TYMP—stomach cancer	0.000206	0.00162	CbGpPWpGaD
Trimetrexate—DHFR—Disease—NPM1—stomach cancer	0.000205	0.00161	CbGpPWpGaD
Trimetrexate—Nausea—Epirubicin—stomach cancer	0.000204	0.0016	CcSEcCtD
Trimetrexate—Vomiting—Doxorubicin—stomach cancer	0.000202	0.00158	CcSEcCtD
Trimetrexate—Rash—Doxorubicin—stomach cancer	0.000201	0.00157	CcSEcCtD
Trimetrexate—Dermatitis—Doxorubicin—stomach cancer	0.000201	0.00157	CcSEcCtD
Trimetrexate—DHFR—Disease—RBP4—stomach cancer	0.000198	0.00156	CbGpPWpGaD
Trimetrexate—DHFR—Disease—RPS26—stomach cancer	0.000195	0.00153	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—BIRC5—stomach cancer	0.000195	0.00153	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PPIA—stomach cancer	0.000193	0.00152	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—SREBF2—stomach cancer	0.000193	0.00151	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—RORA—stomach cancer	0.00019	0.0015	CbGpPWpGaD
Trimetrexate—Nausea—Doxorubicin—stomach cancer	0.000189	0.00148	CcSEcCtD
Trimetrexate—DHFR—Cell Cycle, Mitotic—CDK4—stomach cancer	0.000189	0.00148	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—PRKCB—stomach cancer	0.000186	0.00146	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ALDOB—stomach cancer	0.000178	0.0014	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—CDK4—stomach cancer	0.000169	0.00133	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—PRKCB—stomach cancer	0.000166	0.0013	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ALOX5—stomach cancer	0.000166	0.0013	CbGpPWpGaD
Trimetrexate—DHFR—Disease—RPS19—stomach cancer	0.000166	0.0013	CbGpPWpGaD
Trimetrexate—DHFR—Disease—AKR1C3—stomach cancer	0.000166	0.0013	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—DPYD—stomach cancer	0.000163	0.00128	CbGpPWpGaD
Trimetrexate—DHFR—Disease—ENO1—stomach cancer	0.000162	0.00127	CbGpPWpGaD
Trimetrexate—DHFR—Disease—RPS6—stomach cancer	0.000147	0.00115	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GSTT1—stomach cancer	0.000144	0.00113	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—CDKN2A—stomach cancer	0.000144	0.00113	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CD44—stomach cancer	0.000143	0.00113	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CYP2A6—stomach cancer	0.000143	0.00112	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—AKR1C3—stomach cancer	0.000139	0.00109	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ENO1—stomach cancer	0.000135	0.00106	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HBEGF—stomach cancer	0.000135	0.00106	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—CDKN2A—stomach cancer	0.000129	0.00101	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—CDKN1B—stomach cancer	0.000128	0.001	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—CCND1—stomach cancer	0.000122	0.000958	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PPP2R1A—stomach cancer	0.000122	0.000957	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CD44—stomach cancer	0.00012	0.000942	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—CDKN1A—stomach cancer	0.000118	0.000926	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—CDKN1B—stomach cancer	0.000114	0.000898	CbGpPWpGaD
Trimetrexate—DHFR—Disease—SMAD4—stomach cancer	0.000113	0.000888	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—CCND1—stomach cancer	0.000109	0.000856	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FYN—stomach cancer	0.000107	0.000843	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—CDKN1A—stomach cancer	0.000105	0.000828	CbGpPWpGaD
Trimetrexate—DHFR—Disease—ERCC2—stomach cancer	0.000103	0.000811	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PPP2R1A—stomach cancer	0.000102	0.000801	CbGpPWpGaD
Trimetrexate—DHFR—Disease—FGFR2—stomach cancer	0.000101	0.000792	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—MAPK3—stomach cancer	0.000101	0.00079	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GSTP1—stomach cancer	0.0001	0.000786	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—HMOX1—stomach cancer	9.87e-05	0.000775	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—MYC—stomach cancer	9.78e-05	0.000768	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MTHFR—stomach cancer	9.7e-05	0.000762	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle, Mitotic—MAPK1—stomach cancer	9.57e-05	0.000751	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—TYMS—stomach cancer	9.3e-05	0.000731	CbGpPWpGaD
Trimetrexate—DHFR—Disease—IRS2—stomach cancer	9.23e-05	0.000725	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—GSTM1—stomach cancer	9.19e-05	0.000722	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—MAPK3—stomach cancer	8.99e-05	0.000706	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CAV1—stomach cancer	8.95e-05	0.000703	CbGpPWpGaD
Trimetrexate—DHFR—Disease—APOA1—stomach cancer	8.93e-05	0.000701	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—MYC—stomach cancer	8.74e-05	0.000687	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ERCC2—stomach cancer	8.64e-05	0.000679	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—MAPK1—stomach cancer	8.55e-05	0.000672	CbGpPWpGaD
Trimetrexate—DHFR—Disease—IL6ST—stomach cancer	8.48e-05	0.000666	CbGpPWpGaD
Trimetrexate—DHFR—Disease—APC—stomach cancer	8.15e-05	0.00064	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—MTHFR—stomach cancer	8.13e-05	0.000638	CbGpPWpGaD
Trimetrexate—DHFR—Disease—IL6R—stomach cancer	7.57e-05	0.000595	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—CAV1—stomach cancer	7.5e-05	0.000589	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—APOA1—stomach cancer	7.48e-05	0.000587	CbGpPWpGaD
Trimetrexate—DHFR—Cell Cycle—TP53—stomach cancer	7.18e-05	0.000564	CbGpPWpGaD
Trimetrexate—DHFR—Disease—SERPINE1—stomach cancer	7.09e-05	0.000557	CbGpPWpGaD
Trimetrexate—DHFR—Disease—RHOA—stomach cancer	6.84e-05	0.000537	CbGpPWpGaD
Trimetrexate—DHFR—Disease—NOS3—stomach cancer	6.77e-05	0.000532	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PPARG—stomach cancer	6.59e-05	0.000518	CbGpPWpGaD
Trimetrexate—DHFR—Disease—ERBB2—stomach cancer	6.33e-05	0.000497	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PTGS2—stomach cancer	6.19e-05	0.000486	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—ALB—stomach cancer	5.92e-05	0.000465	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CDKN1B—stomach cancer	5.86e-05	0.00046	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—NOS3—stomach cancer	5.67e-05	0.000445	CbGpPWpGaD
Trimetrexate—DHFR—Disease—CDKN1A—stomach cancer	5.41e-05	0.000425	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PTGS2—stomach cancer	5.18e-05	0.000407	CbGpPWpGaD
Trimetrexate—DHFR—Disease—STAT3—stomach cancer	4.83e-05	0.000379	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MAPK3—stomach cancer	4.61e-05	0.000362	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MYC—stomach cancer	4.49e-05	0.000352	CbGpPWpGaD
Trimetrexate—DHFR—Disease—MAPK1—stomach cancer	4.39e-05	0.000345	CbGpPWpGaD
Trimetrexate—DHFR—Disease—EGFR—stomach cancer	4.39e-05	0.000345	CbGpPWpGaD
Trimetrexate—DHFR—Disease—KRAS—stomach cancer	4.14e-05	0.000326	CbGpPWpGaD
Trimetrexate—DHFR—Disease—PIK3CA—stomach cancer	3.81e-05	0.000299	CbGpPWpGaD
Trimetrexate—DHFR—Disease—HRAS—stomach cancer	3.52e-05	0.000277	CbGpPWpGaD
Trimetrexate—DHFR—Disease—IL6—stomach cancer	3.37e-05	0.000265	CbGpPWpGaD
Trimetrexate—DHFR—Metabolism—PIK3CA—stomach cancer	3.19e-05	0.00025	CbGpPWpGaD
